Murlentamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Murlentamab Usage And Synthesis

Uses

Murlentamab (3C23K; GM102) is a humanized anti-AMHRII antibody. AMHRII is the anti-Müllerian hormone receptor. Murlentama significantly promotes macrophage-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Murlentama stimulates pro-inflammatory and anti-tumor internal environment, recruits and activates T cells. Murlentama suppresses tumors growth by inducing na?ve macrophage orientation and promoting tumor-associated macrophage (TAM) reprogramming[1].

in vivo

References

[1] Prat M, et al. Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation. Cancers (Basel). 2021 Apr 13;13(8):1845. DOI:10.3390/cancers13081845
[2] Barret JM, et al. The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer. Biology (Basel). 2021 Apr 7;10(4):305. DOI:10.3390/biology10040305

Murlentamab(2058047-65-5)Related Product Information

• Regavirumab
• Bedinvetmab
• Unii-9927mt646m
• Tarextumab
• Tomaralimab
• Adintrevimab
• Tesnatilimab
• Minretumomab [inn]
• Talacotuzumab
• Tabituximab